Double Medical Technology Inc. (SZSE:002901) announces a share repurchase program. Under the program, the company will repurchase up to CNY 260 million worth of its shares. The shares will be purchased at a price not exceeding CNY 50 per share. The purchased shares will be used for equity incentives plans. The program will be valid for 12 months from the Directorate approval date.

On June 30, 2026, the company announced that it has adjusted its share repurchase price to CNY 49.41 per share. The adjustment is effective from July 7, 2026.